The regional impairment of brain development in the Brattleboro diabetes insipidus rat; some vasopressin supplementation studies.
D000375:Aging; D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development; D001127:Arginine Vasopressin / Q000627:therapeutic use; D001834:Body Water / Q000378:metabolism; D001921:Brain / Q000254:growth & development* / Q000473:pathology; D002452:Cell Count; D002531:Cerebellum / Q000473:pathology / Q000503:physiopathology; D002540:Cerebral Cortex / Q000503:physiopathology; D004247:DNA / Q000096:biosynthesis; D003919:Diabetes Insipidus / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D008297:Male; D009830:Olfactory Bulb / Q000503:physiopathology; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011910:Rats, Brattleboro / Q000254:growth & development*; D011922:Rats, Mutant Strains / Q000254:growth & development*; D014667:Vasopressins / Q000627:therapeutic use*
C016671:pitressin tannate; D014667:Vasopressins; D001127:Arginine Vasopressin; D004247:DNA